Our findings suggest that SSB1 alleviates ALI by targeting key inflammatory factors, including IL1B, TNF, and IL6, thereby modulating the NOD-like receptor signaling pathway and restoring pulmonary metabolic homeostasis. This evidence concerns the gene TNF and acute respiratory distress syndrome.